1. Magnussen C, Ojeda FM, et al. Global Cardiovascular Risk Consortium. 2023; Global effect of modifiable risk factors on cardiovascular disease and mortality. N Engl J Med. 389:1273–85. DOI:
10.1056/NEJMoa2206916. PMID:
37632466. PMCID:
PMC10589462.
2. Joseph P, Leong D, McKee M, et al. 2017; Reducing the global burden of cardiovascular disease, part 1: the epidemiology and risk factors. Circ Res. 121:677–94. DOI:
10.1161/CIRCRESAHA.117.308903. PMID:
28860318.
3. WHO CVD Risk Chart Working Group. 2019; World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions. Lancet Glob Health. 7:e1332–45. DOI:
10.1016/S2214-109X(19)30318-3. PMID:
31488387. PMCID:
PMC7025029.
4. Statistics Korea. Annual report on the cause of death statistics: nationwide. 2022. Statistics Korea;2023.
5. Li YW, Kao TW, Chang PK, Chen WL, Wu LW. 2021; Atherogenic index of plasma as predictors for metabolic syndrome, hypertension and diabetes mellitus in Taiwan citizens: a 9-year longitudinal study. Sci Rep. 11:9900. DOI:
10.1038/s41598-021-89307-z. PMID:
33972652. PMCID:
PMC8110777.
6. Wu TT, Gao Y, Zheng YY, Ma YT, Xie X. 2018; Atherogenic index of plasma (AIP): a novel predictive indicator for the coronary artery disease in postmenopausal women. Lipids Health Dis. 17:197. DOI:
10.1186/s12944-018-0828-z. PMID:
30134981. PMCID:
PMC6106932.
7. Cai G, Shi G, Xue S, Lu W. 2017; The atherogenic index of plasma is a strong and independent predictor for coronary artery disease in the Chinese Han population. Medicine (Baltimore). 96:e8058. DOI:
10.1097/MD.0000000000008058. PMID:
28906400. PMCID:
PMC5604669.
8. Hammam N, Abdel-Wahab N, Gheita TA. 2021; Atherogenic index of plasma in women with rheumatoid arthritis and systemic lupus erythematosus: a 10-year potential predictor of cardiovascular disease. Curr Rheumatol Rev. 17:122–30. DOI:
10.2174/1573397116666201007123403. PMID:
33030132.
9. Kraus WE, Powell KE, Haskell WL, et al. 2019; Physical activity, all-cause and cardiovascular mortality, and cardiovascular disease. Med Sci Sports Exerc. 51:1270–81. DOI:
10.1249/MSS.0000000000001939. PMID:
31095084. PMCID:
PMC6527136.
10. Lear SA, Hu W, Rangarajan S, et al. 2017; The effect of physical activity on mortality and cardiovascular disease in 130 000 people from 17 high-income, middle-income, and low-income countries: the PURE study. Lancet. 390:2643–54. DOI:
10.1016/S0140-6736(17)31634-3. PMID:
28943267.
11. Wahid A, Manek N, Nichols M, et al. 2016; Quantifying the association between physical activity and cardiovascular disease and diabetes: a systematic review and meta-analysis. J Am Heart Assoc. 5:e002495. DOI:
10.1161/JAHA.115.002495. PMID:
27628572. PMCID:
PMC5079002.
12. Edwards M, Loprinzi P. 2019; The dose-response association between reported moderate to vigorous intensity physical activity and atherogenic index of plasma: NHANES, 1999-2006. J Phys Act Health. 16:368–70. DOI:
10.1123/jpah.2016-0389. PMID:
30920346.
13. Edwards MK, Loprinzi PD. 2016; The association between muscle strengthening activities and atherogenic index of plasma. Prev Med. 91:318–21. DOI:
10.1016/j.ypmed.2016.09.013. PMID:
27616652.
14. Lim JJ, Hei Y, Kim YS. 2022; Association of aerobic and muscle-strengthening activities with AIP in Korean adults: Korea National Health and Nutrition Examination Survey 2014-2019. J Korean Assoc Phys Educ Sport Girls Women. 36:245–58. DOI:
10.16915/jkapesgw.2022.9.36.3.245.
16. Gallucci G, Tartarone A, Lerose R, Lalinga AV, Capobianco AM. 2020; Cardiovascular risk of smoking and benefits of smoking cessation. J Thorac Dis. 12:3866–76. DOI:
10.21037/jtd.2020.02.47. PMID:
32802468. PMCID:
PMC7399440.
17. Duncan MS, Freiberg MS, Greevy RA Jr, Kundu S, Vasan RS, Tindle HA. 2019; Association of smoking cessation with subsequent risk of cardiovascular disease. JAMA. 322:642–50. DOI:
10.1001/jama.2019.10298. PMID:
31429895. PMCID:
PMC6704757.
18. Heydari G, Hosseini M, Yousefifard M, Asady H, Baikpour M, Barat A. 2015; Smoking and physical activity in healthy adults: a cross-sectional study in Tehran. Tanaffos. 14:238–45. PMID:
27114725. PMCID:
PMC4841990.
21. Ministry of Health and Welfare. Physical activity guidelines for Koreans. Korean Health Promotion Institute;2023.
23. Manson JE, Greenland P, LaCroix AZ, et al. 2002; Walking compared with vigorous exercise for the prevention of cardiovascular events in women. N Engl J Med. 347:716–25. DOI:
10.1056/NEJMoa021067. PMID:
12213942.
24. Lim JO, Yang HS, Choi SE, Kim WN. 2015; Cigarette smoking and risk of cardiovascular and lung disease in Korea: a cross-sectional survey data analysis. J Korean Data Anal Soc. 17:3131–40.
25. Schroeder EC, Franke WD, Sharp RL, Lee DC. 2019; Comparative effectiveness of aerobic, resistance, and combined training on cardiovascular disease risk factors: a randomized controlled trial. PLoS One. 14:e0210292. DOI:
10.1371/journal.pone.0210292. PMID:
30615666. PMCID:
PMC6322789.
26. Ho SS, Dhaliwal SS, Hills AP, Pal S. 2012; The effect of 12 weeks of aerobic, resistance or combination exercise training on cardiovascular risk factors in the overweight and obese in a randomized trial. BMC Public Health. 12:704. DOI:
10.1186/1471-2458-12-704. PMID:
23006411. PMCID:
PMC3487794.
27. Bennie JA, Ding D, Khan A, Stamatakis E, Biddle SJ, Kim J. 2020; Run, lift, or both?: associations between concurrent aerobic-muscle strengthening exercise with adverse cardiometabolic biomarkers among Korean adults. Eur J Prev Cardiol. 27:738–48. DOI:
10.1177/2047487318817899. PMID:
30861691.
28. Yang Y, Xu H, Liu X, et al. 2022; Joint association of smoking and physical activity with mortality in elderly hypertensive patients: a Chinese population-based cohort study in 2007-2018. Front Public Health. 10:1005260. DOI:
10.3389/fpubh.2022.1005260. PMID:
36249230. PMCID:
PMC9558130.
29. Lallukka T, Lahti J, Lahelma E, Rahkonen O. 2016; The contribution of smoking to mortality during working age at different levels of leisure-time physical activity. Eur J Public Health. 26:826–30. DOI:
10.1093/eurpub/ckw065. PMID:
27161910.